Pierre Wallemacq

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

Pierre Wallemacq, Victor W. Armstrong, Merçè Brunet et al. · Therapeutic Drug Monitoring · 2009 · 463 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

Vincent Haufroid, Michel Mourad, Val rie Van Kerckhove et al. · Pharmacogenetics · 2004 · 445 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

Fabio Silvio Taccone, Pierre‐François Laterre, Thierry Dugernier et al. · Critical Care · 2010 · 372 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock

Fabio Silvio Taccone, Pierre‐François Laterre, Herbert Spapen et al. · Critical Care · 2010 · 199 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance.

Martin Buysschaert, Anne-Sophie Dramais, Pierre Wallemacq et al. · Diabetes Care · 2000 · 192 citations · Full text

Medicine, Endocrinology, Internal Medicine +16